Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
5(29%)
Results Posted
100%(5 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_3
1
6%
Ph not_applicable
5
29%
Ph phase_2
4
24%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

5

trials recruiting

Total Trials

17

all time

Status Distribution
Active(7)
Completed(5)
Terminated(1)
Other(4)

Detailed Status

Completed5
Recruiting5
unknown4
Terminated1
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
5
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (40.0%)
Phase 31 (10.0%)
N/A5 (50.0%)

Trials by Status

completed529%
terminated16%
not_yet_recruiting16%
recruiting529%
unknown424%
enrolling_by_invitation16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT05027425Phase 2

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Terminated
NCT06140134

Liver Transplantation in Intrahepatic Cholangiocarcinoma

Recruiting
NCT04234139

Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation

Enrolling By Invitation
NCT04742621

Liver Transplantation for Unresectable Liver Limited Colorectal Metastases

Recruiting
NCT02818218

Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation

Completed
NCT04993131Not Applicable

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

Recruiting
NCT06910722Not Applicable

Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy

Not Yet Recruiting
NCT04556214Not Applicable

Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)

Recruiting
NCT03803436Phase 2

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Unknown
NCT04499833Not Applicable

HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma

Recruiting
NCT03874286

The TOGETHER Project - Liver

Completed
NCT04506398

Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Unknown
NCT04870879Not Applicable

Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors

Unknown
NCT03814772

To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBM

Unknown
NCT00135694Phase 2

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

Completed
NCT02717273Phase 3

Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics

Completed
NCT00105235Phase 2

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

Completed

All 17 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
17